drugset / Trial / NCT01340911
A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases
RandomizedParallel-groupSingle-blindBasic science
Summary
The main purpose of the study is to see how safe SRT3025 (study drug) is when given at different doses. The study will also investigate how the study drug is taken up, metabolised (chemically broken down), distributed through the body and excreted. A further aim is to look at how taking the study drug after eating might change this process.
Timeline
- Start
- 2011-06-03
- Primary completion
- 2011-11-24
- Completion
- 2011-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | SRT3025 | Unknown | 50 mg | — |
| Comparator | SRT3025 | Unknown | 150 mg | — |
| Comparator | SRT3025 | Unknown | 500 mg | — |
| Comparator | SRT3025 | Unknown | 1000 mg | — |
| Comparator | SRT3025 | Unknown | 2000 mg | — |
| Comparator | SRT3025 | Unknown | 3000 mg | — |